Document:

EX-4.5

 Exhibit 4.5 

THIS WARRANT AND THE SHARES ISSUABLE UPON EXERCISE THEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES
LAWS. NO SALE OR DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED,
(iii) RECEIPT OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THIS WARRANT. 

MOHAWK GROUP HOLDINGS, INC. 

WARRANT TO PURCHASE SHARES 
 OF
COMMON STOCK 
 (LOAN [A/B/C]) 

THIS CERTIFIES THAT, for value received, HORIZON TECHNOLOGY FINANCE CORPORATION and its assignees are entitled to subscribe for and purchase
[100,000/100,000/100,000] of the fully paid and nonassessable shares of common stock (the “Common Stock”) (as adjusted pursuant to Section 4 hereof, the “Shares”) of MOHAWK GROUP HOLDINGS, INC., a Delaware corporation (the
“Company”), at the price of $4.00 per share (such price and such other price as shall result, from time to time, from the adjustments specified in Section 4 hereof is herein referred to as the “Warrant Price”), subject to
the provisions and upon the terms and conditions hereinafter set forth. As used herein, (a) the term “Date of Grant” shall mean December __, 2018, and (b) the term “Other Warrants” shall mean any other warrants issued
by the Company in connection with the transaction with respect to which this Warrant was issued, and any warrant issued upon transfer or partial exercise of or in lieu of this Warrant. The term “Warrant” as used herein shall be deemed to
include Other Warrants unless the context clearly requires otherwise. 
 1. Term. The purchase right represented by this Warrant is
exercisable, in whole or in part, at any time and from time to time from the Date of Grant through the earlier of (i) ten (10) years after the Date of Grant or (ii) five (5) years after the closing of the Company’s initial
public offering of the Common Stock (“IPO”) effected pursuant to a Registration Statement on Form S-1 (or its successor) filed under the Securities Act of 1933, as amended (the “Act”). 

2. Method of Exercise; Payment; Issuance of New Warrant. Subject to Section 1 hereof, the purchase right represented by this
Warrant may be exercised by the holder hereof, in whole or in part and from time to time, at the election of the holder hereof, by (a) the surrender of this Warrant (with the notice of exercise substantially in the form attached hereto as
Exhibit A-1 duly completed and executed) at the principal office of the Company and by the payment to the Company, by certified or bank check, or by wire transfer to an account designated by the Company (a “Wire Transfer”) of an
amount equal to the then applicable Warrant Price multiplied by the number of Shares then being purchased; (b) if in connection with a registered public offering of the Company’s securities by selling stockholders, the surrender of this
Warrant (with the notice of exercise form attached hereto as Exhibit A-2 duly completed and executed) at the principal office of the Company together with notice of arrangements reasonably satisfactory to the Company for payment to the Company
either by certified or bank check or by Wire Transfer from the proceeds of the sale of shares to be sold by the holder in such public offering of an amount equal to the then applicable Warrant Price per share

 
multiplied by the number of Shares then being purchased; or (c) exercise of the “net issuance” right provided for in Section 10.2 hereof. The person or persons in whose
name(s) any certificate(s) representing the Shares shall be issuable upon exercise of this Warrant shall be deemed to have become the holder(s) of record of, and shall be treated for all purposes as the record holder(s) of, the Shares represented
thereby (and such Shares shall be deemed to have been issued) immediately prior to the close of business on the date or dates upon which this Warrant is exercised. In the event of any exercise of the rights represented by this Warrant, certificates
for the Shares so purchased (in the case of certificated securities) shall be delivered to the holder hereof as soon as possible and in any event within thirty (30) days after such exercise and, unless this Warrant has been fully exercised or
expired, a new Warrant representing the portion of the Shares, if any, with respect to which this Warrant shall not then have been exercised shall also be issued to the holder hereof as soon as possible and in any event within such thirty-day
period; provided, however, at such time as the Company is subject to the reporting requirements of the Securities Exchange Act of 1934, as amended, if requested by the holder of this Warrant, the Company shall use its commercially reasonable
efforts to cause its transfer agent to deliver the certificate representing Shares issued upon exercise of this Warrant (in the case of certificated securities) to a broker or other person (as directed by the holder exercising this Warrant) within
the time period required to settle any trade made by the holder after exercise of this Warrant. 
 3. Stock Fully Paid; Reservation of
Shares. All Shares that may be issued upon the exercise of the rights represented by this Warrant will, upon issuance pursuant to the terms and conditions herein, be duly authorized, validly issued, fully paid and nonassessable, and free from
all preemptive rights and taxes, liens and charges with respect to the issue thereof. During the period within which the rights represented by this Warrant may be exercised, the Company will at all times have authorized, and reserved for the purpose
of the issue upon exercise of the purchase rights evidenced by this Warrant, a sufficient number of Shares to provide for the exercise of the rights represented by this Warrant. 

4. Adjustment of Warrant Price and Number of Shares. The number and kind of securities purchasable upon the exercise of this Warrant
and the Warrant Price shall be subject to adjustment from time to time upon the occurrence of certain events, as follows: 
 (a)
Reclassification or Merger. In case of any reclassification or change of securities of the class issuable upon exercise of this Warrant (other than a change in par value, or from par value to no par value, or from no par value to par value,
or as a result of a subdivision or combination), or in case of any merger of the Company with or into another entity (other than a merger with another entity in which the Company is the acquiring and the surviving entity and which does not result in
any reclassification or change of outstanding securities issuable upon exercise of this Warrant), or in case of any sale of all or substantially all of the assets of the Company, the Company, or such successor or purchasing entity, as the case may
be, shall duly execute and deliver to the holder of this Warrant a new Warrant (in form and substance satisfactory to the holder of this Warrant), so that the holder of this Warrant shall have the right to receive upon exercise of such new Warrant,
at a total purchase price not to exceed that payable upon the exercise of the unexercised portion of this Warrant, and in lieu of the Shares theretofore issuable upon exercise of this Warrant, (i) the kind and amount of shares of stock, other
securities, money and property receivable upon such reclassification, change, merger or sale by a holder of the number of Shares then purchasable under this Warrant, or (ii) in the case of such a merger or sale in which the consideration paid
consists all or in part of assets other than securities of the successor or purchasing entity, at the option of the holder of this Warrant, 

  
 -2- 

 
the securities of the successor or purchasing entity having a value at the time of the transaction equivalent to the value of the Shares purchasable upon exercise of this Warrant at the time of
the transaction. Any new Warrant shall provide for adjustments that shall be as nearly equivalent as may be practicable to the adjustments provided for in this Section 4. The provisions of this Section 4(a) shall similarly apply to
successive reclassifications, changes, mergers and sales. 
 (b) Subdivision or Combination of Shares. If the Company at any time
while this Warrant remains outstanding and unexpired shall subdivide or combine its outstanding Shares, the Warrant Price shall be proportionately decreased and the number of Shares issuable hereunder shall be proportionately increased in the case
of a subdivision and the Warrant Price shall be proportionately increased and the number of Shares issuable hereunder shall be proportionately decreased in the case of a combination. 

(c) Stock Dividends and Other Distributions. If the Company at any time while this Warrant is outstanding and unexpired shall
(i) pay a dividend with respect to Shares payable in Shares, then the Warrant Price shall be adjusted, from and after the date of determination of stockholders entitled to receive such dividend or distribution, to that price determined by
multiplying the Warrant Price in effect immediately prior to such date of determination by a fraction (A) the numerator of which shall be the total number of Shares outstanding immediately prior to such dividend or distribution, and
(B) the denominator of which shall be the total number of Shares outstanding immediately after such dividend or distribution; or (ii) make any other distribution with respect to Shares (except any distribution specifically provided for in
Sections 4(a) and 4(b)), then, in each such case, provision shall be made by the Company such that the holder of this Warrant shall receive upon exercise of this Warrant a proportionate share of any such dividend or distribution as though it
were the holder of the Shares as of the record date fixed for the determination of the stockholders of the Company entitled to receive such dividend or distribution. 

(d) Adjustment of Number of Shares. Upon each adjustment in the Warrant Price, the number of Shares purchasable hereunder shall be
adjusted, to the nearest whole share, to the product obtained by multiplying the number of Shares purchasable immediately prior to such adjustment in the Warrant Price by a fraction, the numerator of which shall be the Warrant Price immediately
prior to such adjustment and the denominator of which shall be the Warrant Price immediately thereafter. 
 5. Notice of Adjustments.
Whenever the Warrant Price or the number of Shares purchasable hereunder shall be adjusted pursuant to Section 4 hereof, the Company shall prepare a certificate signed by its chief financial officer setting forth, in reasonable detail, the
event requiring the adjustment, the amount of the adjustment, the method by which such adjustment was calculated, and the Warrant Price and the number of Shares purchasable hereunder after giving effect to such adjustment, and shall cause copies of
such certificate to be mailed (without regard to Section 13 hereof, by first class mail, postage prepaid) to the holder of this Warrant. 

6. Fractional Shares. No fractional Shares will be issued in connection with any exercise hereunder, but in lieu of such fractional
shares the Company shall make a cash payment therefor based on the fair market value of a Share on the date of exercise as reasonably determined in good faith by the Company’s Board of Directors. 

  
 -3- 

 7. Compliance with Act; Disposition of Warrant or Shares. 

(a) Compliance with Act. The holder of this Warrant, by acceptance hereof, agrees that this Warrant, and the Shares to be issued upon
exercise hereof, are being acquired for investment and that such holder will not offer, sell or otherwise dispose of this Warrant, or any Shares to be issued upon exercise hereof except under circumstances which will not result in a violation of the
Act or any applicable state securities laws, and shall in no event transfer this Warrant to any competitor of the Company or any of its subsidiaries without the Company’s prior written consent. Upon exercise of this Warrant, unless the Shares
being acquired are registered under the Act and any applicable state securities laws or an exemption from such registration is available, the holder hereof shall confirm in writing that the Shares so purchased are being acquired for investment and
not with a view toward distribution or resale in violation of the Act and shall confirm such other matters related thereto as may be reasonably requested by the Company. This Warrant and all Shares issued upon exercise of this Warrant (unless
registered under the Act and any applicable state securities laws) shall be stamped or imprinted with a legend in substantially the following form: 

“THE SECURITIES EVIDENCED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. NO SALE OR
DISPOSITION MAY BE EFFECTED WITHOUT (i) EFFECTIVE REGISTRATION STATEMENTS RELATED THERETO, (ii) AN OPINION OF COUNSEL OR OTHER EVIDENCE, REASONABLY SATISFACTORY TO THE COMPANY, THAT SUCH REGISTRATIONS ARE NOT REQUIRED, (iii) RECEIPT
OF NO-ACTION LETTERS FROM THE APPROPRIATE GOVERNMENTAL AUTHORITIES, OR (iv) OTHERWISE COMPLYING WITH THE PROVISIONS OF SECTION 7 OF THE WARRANT UNDER WHICH THESE SECURITIES WERE ISSUED, DIRECTLY OR INDIRECTLY.” 

Said legend shall be removed by the Company, upon the request of a holder, at such time as the restrictions on the transfer of the applicable
security shall have terminated. In addition, in connection with the issuance of this Warrant, the holder specifically represents, warrants and covenants to the Company by acceptance of this Warrant as follows: 

(1) The holder is aware of the Company’s business affairs and financial condition, and has acquired information about the Company
sufficient to reach an informed and knowledgeable decision to acquire this Warrant. The holder is acquiring this Warrant for its own account for investment purposes only and not with a view to, or for the resale in connection with, any
“distribution” thereof in violation of the Act. 
 (2) The holder understands that this Warrant has not been registered under the
Act in reliance upon a specific exemption therefrom, which exemption depends upon, among other things, the bona fide nature of the holder’s investment intent as expressed herein. 

(3) The holder further understands that this Warrant must be held indefinitely unless subsequently registered under the Act and qualified
under any applicable state securities laws, or unless exemptions from registration and qualification are otherwise available. The holder is aware of the provisions of Rule 144, promulgated under the Act. 

(4) The holder is an “accredited investor” as such term is defined in Rule 501 of Regulation D promulgated under the Act.

  
 -4- 

 (5) If requested by the underwriters, the holder shall not sell, transfer, make any short
sale of, grant any option for the purchase of, or enter into any hedging or similar transaction with the same economic effect as a sale, any shares of Common Stock (or other securities) of the Company held by the holder (other than those included in
the registration) during the 180-day period following the effective date of the IPO (or such longer period as the underwriters or the Company shall request in order to facilitate compliance with NASD Rule 2711 or NYSE Member Rule 472 or any
successor or similar rule or regulation); provided that all officers and directors of the Company and holders of at least one percent (1%) of the Company’s voting securities are bound by and have entered into similar agreements. The
obligations described in this Section 7(a)(5) shall not apply to a registration relating solely to employee benefit plans on Form S-1 or Form S-8 or similar forms that may be promulgated in the future, or a registration relating solely to a
transaction on Form S-4 or similar forms that may be promulgated in the future. 
 (b) Disposition of Warrant or Shares. With respect
to any offer, sale or other disposition of this Warrant or any Shares acquired pursuant to the exercise of this Warrant prior to registration of such Warrant or Shares, the holder hereof agrees to give written notice to the Company prior thereto,
describing briefly the manner thereof, together with a written opinion of such holder’s counsel, or other evidence if reasonably satisfactory to the Company, to the effect that such offer, sale or other disposition may be effected without
registration or qualification (under the Act as then in effect or any federal or state securities law then in effect) of this Warrant or such Shares and indicating whether or not under the Act certificates for this Warrant or such Shares (in the
case of certificated securities) to be sold or otherwise disposed of require any restrictive legend as to applicable restrictions on transferability in order to ensure compliance with such law. Upon receiving such written notice and reasonably
satisfactory opinion or other evidence, the Company, as promptly as practicable but no later than fifteen (15) days after receipt of the written notice, shall notify such holder that such holder may sell or otherwise dispose of this Warrant or
such Shares, all in accordance with the terms of the notice delivered to the Company. If a determination has been made pursuant to this Section 7(b) that the opinion of counsel for the holder or other evidence is not reasonably satisfactory to
the Company, the Company shall so notify the holder promptly with details thereof after such determination has been made. Notwithstanding the foregoing, this Warrant or such Shares may, as to such federal laws, be offered, sold or otherwise disposed
of in accordance with Rule 144 or 144A under the Act (respectively, “Rule 144” and “Rule 144A”), provided that the Company shall have been furnished with such information as the Company may reasonably request to provide a
reasonable assurance that the provisions of Rule 144 or 144A have been satisfied. Each certificate representing this Warrant or the Shares (in the case of certificated securities) thus transferred (except a transfer pursuant to Rule 144 or
144A) shall bear a legend as to the applicable restrictions on transferability in order to ensure compliance with such laws, unless in the aforesaid opinion of counsel for the holder, such legend is not required in order to ensure compliance with
such laws. The Company may issue stop transfer instructions to its transfer agent in connection with such restrictions. 
 (c)
Applicability of Restrictions. Neither any restrictions of any legend described in this Warrant nor the requirements of Section 7(b) above shall apply to any transfer of, or grant of a security interest in, this Warrant (or the Shares
obtainable upon exercise thereof) or any part hereof (i) to a partner of the holder if the holder is a partnership or to a member of the holder if the holder is a limited liability company, (ii) to a partnership of which the holder is a
partner or to a limited liability company of which the holder is a member, (iii) to any affiliate of the holder if the holder is a corporation, (iv) notwithstanding the foregoing, to any corporation, company, limited liability

  
 -5- 

 
company, limited partnership, partnership, or other person managed or sponsored by Horizon Technology Finance Corporation (“HRZN”) or in which HRZN has an interest, (v) or to a
lender to the holder or any of the foregoing; provided, however, in any such transfer, if applicable, the transferee shall on the Company’s request agree in writing (with a copy delivered to the Company in accordance with
Section 13 hereof) to be bound by the terms of this Warrant as if an original holder hereof. 
 8. Rights as Stockholders;
Information. No holder of this Warrant, as such, shall be entitled to vote or receive dividends or be deemed the holder of Shares or any other securities of the Company which may at any time be issuable upon the exercise hereof for any purpose,
nor shall anything contained herein be construed to confer upon the holder of this Warrant, as such, any of the rights of a stockholder of the Company or any right to vote for the election of directors or upon any matter submitted to stockholders at
any meeting thereof, or to receive notice of meetings, or to receive dividends or subscription rights or otherwise until this Warrant shall have been exercised and the Shares purchasable upon the exercise hereof shall have become deliverable, as
provided herein. Notwithstanding the foregoing, the Company will transmit to the holder of this Warrant (a) such information, documents and reports as are generally distributed to the holders of any class or series of the securities of the
Company concurrently with the distribution thereof to the stockholders, (b) any stock purchase (or similar) agreement to which the Company is a party entered into on or after the Date of Grant pursuant to which the Company issues shares of
Common Stock, other than agreements relating to the grant of equity awards or the issuance of shares of Common Stock pursuant to awards granted pursuant to the Company’s equity incentive plans, (c) each amendment to, or amended and
restated, Charter filed by the Company with the Secretary of State of any jurisdiction, and (d) prior to the IPO, on the first day of each calendar quarter, the Company’s then current capitalization table, showing the number of issued and
outstanding equity securities of the Company, together with the number of outstanding options and warrants to purchase such equity securities issued by the Company; provided, however that any material to be delivered pursuant to this sentence shall
be deemed delivered hereunder upon posting thereof on the EDGAR Website (or any successor system thereto) maintained by the U.S. Securities and Exchange Commission. 

9. INTENTIONALLY OMITTED. 
 10.
Additional Rights. 
 10.1 Acquisition Transactions. The Company shall provide the holder of this Warrant with at least twenty
(20) days’ written notice prior to closing thereof of the terms and conditions of any of the following transactions (to the extent the Company has notice thereof): (i) the sale, lease, exchange, conveyance or other disposition of all
or substantially all of the Company’s property or business, or (ii) its merger into or consolidation with any other corporation (other than a wholly-owned subsidiary of the Company), or any transaction (including a merger or other
reorganization) or series of related transactions, in which more than 50% of the voting power of the Company is disposed of. 
 10.2
Right to Convert Warrant into Stock: Net Issuance. 
 (a) Right to Convert. In addition to and without limiting the rights of
the holder under the terms of this Warrant, the holder shall have the right to convert this Warrant or any portion thereof (the “Conversion Right”) into Shares as provided in this Section 10.2 at any time or from time to time during
the term of this Warrant. Upon exercise of the Conversion Right with respect to a particular number of Shares subject to this Warrant (the “Converted Warrant Shares”), the Company shall deliver to the holder (without payment by the holder
of any exercise price or any cash or other consideration) that number of fully paid and nonassessable Shares as is determined according to the following formula: 

  
 -6- 

													
	 X = B - A             

Y                
	  		  		  		  		  		  	
		
	Where:  X =         	  	the number of Shares that shall be issued to holder
		
	Y =         	  	the fair market value of one Share
		
	A =         	  	the aggregate Warrant Price of the specified number of Converted Warrant Shares immediately prior to the exercise of the Conversion Right (i.e., the number of Converted Warrant Shares multiplied by the
Warrant Price)
		
	B =         	  	the aggregate fair market value of the specified number of Converted Warrant Shares (i.e., the number of Converted Warrant Shares multiplied by the fair market value of one Converted Warrant
Share)

 No fractional Shares shall be issuable upon exercise of the Conversion Right, and, if the number of Shares to
be issued determined in accordance with the foregoing formula is other than a whole number, the Company shall pay to the holder an amount in cash equal to the fair market value of the resulting fractional Share on the Conversion Date (as hereinafter
defined). For purposes of Section 10 of this Warrant, Shares issued pursuant to the Conversion Right shall be treated as if they were issued upon the exercise of this Warrant. 

(b) Method of Exercise. The Conversion Right may be exercised by the holder by the surrender of this Warrant at the principal office of
the Company together with a written statement (which may be in the form of Exhibit A-1 or Exhibit A-2 hereto) specifying that the holder thereby intends to exercise the Conversion Right and indicating the number of Shares subject to this
Warrant which are being surrendered (referred to in Section 10.2(a) hereof as the Converted Warrant Shares) in exercise of the Conversion Right. Such conversion shall be effective upon receipt by the Company of this Warrant together with the
aforesaid written statement, or on such later date as is specified therein (the “Conversion Date”), and, at the election of the holder hereof, may be made contingent upon the closing of the sale of the Common Stock to the public in a
public offering pursuant to a Registration Statement filed under the Act (a “Public Offering”). Certificates for the Shares issuable upon exercise of the Conversion Right (in the case of certificated securities) and, if applicable, a new
warrant evidencing the balance of the Shares remaining subject to this Warrant, shall be issued as of the Conversion Date and shall be delivered to the holder within thirty (30) days following the Conversion Date; provided, however, if
requested by the holder of this Warrant, the Company shall use its commercially reasonable efforts to cause its transfer agent to deliver the certificate representing Shares issued upon exercise of this Warrant to a broker or other person (as
directed by the holder exercising this Warrant) within the time period required to settle any trade made by the holder after exercise of this Warrant. 

(c) Determination of Fair Market Value. For purposes of this Section 10.2, “fair market value” of a Share as of a
particular date (the “Determination Date”) shall mean: 

  
 -7- 

 (i) If the Conversion Right is exercised in connection with and contingent upon a Public
Offering, and if the Company’s Registration Statement relating to such Public Offering (“Registration Statement”) has been declared effective by the Securities and Exchange Commission, then the initial “Price to Public”
specified in the final prospectus with respect to such offering. 
 (ii) If the Conversion Right is not exercised in connection with and
contingent upon a Public Offering, then as follows: 
 (A) If traded on a securities exchange, the fair market value of the Common Stock
shall be deemed to be the average of the closing prices of the Common Stock on such exchange over the five trading days immediately prior to the Determination Date; 

(B) If traded on the Nasdaq Stock Market or other over-the-counter system, the fair market value of the Common Stock shall be deemed to be the
average of the closing prices of the Common Stock over the five trading days immediately prior to the Determination Date; and 
 (C) If
there is no public market for the Common Stock, then fair market value shall be determined by the Board of Directors of the Company in good faith. 
 In
making a determination under clauses (A) or (B) above, if on the Determination Date, five trading days had not passed since the IPO, then the fair market value of the Common Stock shall be the average closing prices or closing bid prices,
as applicable, for the shorter period beginning on and including the date of the IPO and ending on the trading day prior to the Determination Date (or if such period includes only one trading day, the closing price or closing bid price, as
applicable, for such trading day). If closing prices or closing bid prices are no longer reported by a securities exchange or other trading system, the closing price or closing bid price shall be that which is reported by such securities exchange or
other trading system at 4:00 p.m. New York City time on the applicable trading day. 
 10.3 Exercise Prior to Expiration. To the
extent this Warrant is not previously exercised as to all of the Shares subject hereto, and if the fair market value of one Share is greater than the Warrant Price then in effect, this Warrant shall be deemed automatically exercised pursuant to
Section 10.2 above (even if not surrendered) immediately before its expiration. For purposes of such automatic exercise, the fair market value of one Share upon such expiration shall be determined pursuant to Section 10.2(c). To the extent
this Warrant or any portion thereof is deemed automatically exercised pursuant to this Section 10.3, the Company agrees to promptly notify the holder hereof of the number of Shares, if any, the holder hereof is to receive by reason of such
automatic exercise. 
 11. Representations and Warranties of the Company. The Company represents and warrants to the holder of this
Warrant as follows: 
 (a) This Warrant has been duly authorized and executed by the Company and is a valid and binding obligation of the
Company enforceable in accordance with its terms, subject to laws of general application relating to bankruptcy, insolvency and the relief of debtors and the rules of law or principles at equity governing specific performance, injunctive relief and
other equitable remedies. 
 (b) The Shares have been duly authorized and reserved for issuance by the Company and, when issued in
accordance with the terms hereof, will be validly issued, fully paid and nonassessable and free from preemptive rights, taxes, liens and charges with respect to the issue thereof. 

  
 -8- 

 (c) The rights, preferences, privileges and restrictions granted to or imposed upon the
Shares and the holders thereof are as set forth in the Company’s Certificate of Incorporation (the “Charter”). 
 (d)
INTENTIONALLY OMITTED. 
 (e) The execution and delivery of this Warrant are not, and the issuance of the Shares upon exercise of this
Warrant in accordance with the terms hereof will not be, inconsistent with the Charter or the Company’s by-laws, do not and will not contravene any law, governmental rule or regulation, judgment or order applicable to the Company, and do not
and will not conflict with or contravene any provision of, or constitute a default under, any indenture, mortgage, contract or other instrument of which the Company is a party or by which it is bound or require the consent or approval of, the giving
of notice to, the registration or filing with or the taking of any action in respect of or by, any Federal, state or local government authority or agency or other person, except for the filing of notices pursuant to federal and state securities
laws, which filings will be effected by the time required thereby. 
 (f) There are no actions, suits, audits, investigations or proceedings
pending or, to the knowledge of the Company, threatened against the Company in any court or before any governmental commission, board or authority which, if adversely determined, could have a material adverse effect on the ability of the Company to
perform its obligations under this Warrant. 
 (g) The number of shares of Common Stock of the Company outstanding on the date hereof, on a
fully diluted basis (assuming the conversion of all outstanding convertible securities and the exercise of all outstanding options and warrants), does not exceed 54,100,000 shares. 

12. Modification and Waiver. This Warrant and any provision hereof may be changed, waived, discharged or terminated only by an
instrument in writing signed by the party against which enforcement of the same is sought. 
 13. Notices. Any notice, request,
communication or other document required or permitted to be given or delivered to the holder hereof or the Company shall be delivered, or shall be sent by certified or registered mail, postage prepaid, to each such holder at its address as shown on
the books of the Company or to the Company at the address indicated therefor on the signature page of this Warrant. 
 14. Binding Effect
on Successors. This Warrant shall be binding upon any entity succeeding the Company by merger, consolidation or acquisition of all or substantially all of the Company’s assets, and all of the obligations of the Company relating to the
Shares issuable upon the exercise or conversion of this Warrant shall survive the exercise, conversion and termination of this Warrant and all of the covenants and agreements of the Company shall inure to the benefit of the successors and assigns of
the holder hereof. 
 15. Lost Warrants or Stock Certificates. The Company covenants to the holder hereof that, upon receipt of
evidence reasonably satisfactory to the Company of the loss, theft, destruction or 

  
 -9- 

 
mutilation of this Warrant or any stock certificate and, in the case of any such loss, theft or destruction, upon receipt of an indemnity reasonably satisfactory to the Company (including the
posting of any bond as may be required by the Company’s transfer agent), or in the case of any such mutilation upon surrender and cancellation of such Warrant or stock certificate, the Company will make and deliver a new Warrant or stock
certificate, of like tenor, in lieu of the lost, stolen, destroyed or mutilated Warrant or stock certificate. 
 16. Descriptive
Headings. The descriptive headings of the various Sections of this Warrant are inserted for convenience only and do not constitute a part of this Warrant. The language in this Warrant shall be construed as to its fair meaning without regard to
which party drafted this Warrant. 
 17. Governing Law. This Warrant shall be construed and enforced in accordance with, and the
rights of the parties shall be governed by, the laws of the State of Delaware without regard to conflict of law principles thereof. 
 18.
Survival of Representations, Warranties and Agreements. All representations and warranties of the Company and the holder hereof contained herein shall survive the Date of Grant, the exercise or conversion of this Warrant (or any part hereof)
or the termination or expiration of rights hereunder. All agreements of the Company and the holder hereof contained herein shall survive indefinitely until, by their respective terms, they are no longer operative. 

19. Remedies. In case any one or more of the covenants, representations and warranties or agreements contained in this Warrant shall
have been breached, the holders hereof (in the case of a breach by the Company), or the Company (in the case of a breach by a holder), may proceed to protect and enforce their or its rights either by suit in equity and/or by action at law,
including, but not limited to, an action for damages as a result of any such breach and/or an action for specific performance of any such covenant or agreement contained in this Warrant. 

20. No Impairment of Rights. The Company will not, by amendment of the Charter or through any other means, avoid or seek to avoid the
observance or performance of any of the terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such action as may be necessary or appropriate in order to protect the rights of
the holder of this Warrant against impairment. 
 21. Severability. The invalidity or unenforceability of any provision of this
Warrant in any jurisdiction shall not affect the validity or enforceability of such provision in any other jurisdiction, or affect any other provision of this Warrant, which shall remain in full force and effect. 

22. Recovery of Litigation Costs. If any legal action or other proceeding is brought for the enforcement of this Warrant, or because of
an alleged dispute, breach, default, or misrepresentation in connection with any of the provisions of this Warrant, the successful or prevailing party or parties shall be entitled to recover reasonable attorneys’ fees and other costs incurred
in that action or proceeding, in addition to any other relief to which it or they may be entitled. 
 23. Entire Agreement;
Modification. This Warrant constitutes the entire agreement between the parties pertaining to the subject matter contained in it and supersedes all prior and contemporaneous agreements, representations, and undertakings of the parties, whether
oral or written, with respect to such subject matter. 

  
 -10- 

 [Remainder of page intentionally blank. Signature page follows.] 

  
 -11- 

 The Company has caused this Warrant to be duly executed and delivered as of the Date of
Grant specified above. 
  

			
	MOHAWK GROUP HOLDINGS, INC.

 
			
		
	By:	 	 

 
			
		
	Name:	 	 

 
			
		
	Title:	 	 

 
			
		
	Address:	 	 37 East 18th St.,
7th Floor
 New York, NY 10003

 [SIGNATURE PAGE TO WARRANT (LOAN [A/B/C])] 

 EXHIBIT A-1 

NOTICE OF EXERCISE 
  

	To:	 MOHAWK GROUP HOLDINGS, INC. (the “Company”) 

1. The undersigned hereby: 
  

	 	☐	 elects to purchase              shares of
Common Stock of the Company pursuant to the terms of the attached Warrant, and tenders herewith payment of the purchase price of such shares in full, or 

  

	 	☐	 elects to exercise its net issuance rights pursuant to Section 10.2 of the attached Warrant with respect
to              Shares of Common Stock. 

 2. Please
issue a certificate or certificates representing              shares in the name of the undersigned or in such other name or names as are specified below: 

 
  

(Name) 
  

 
  

 
  

(Address) 
 3. The undersigned
represents that the aforesaid shares are being acquired for the account of the undersigned for investment and not with a view to, or for resale in connection with, the distribution thereof and that the undersigned has no present intention of
distributing or reselling such shares, all except as in compliance with applicable securities laws. 
  

	
	
	                    
	(Signature)

  
  

      (Date) 

 EXHIBIT A-2 

NOTICE OF EXERCISE 
  

	To:	 MOHAWK GROUP HOLDINGS, INC. (the “Company”) 

1. Contingent upon and effective immediately prior to the closing (the “Closing”) of the public offering of the Company’s common
stock contemplated by the Registration Statement on Form S-        , filed under the Securities Act of 1933, as amended, on
                , 20        , as amended, the undersigned hereby: 

☐ elects to purchase              shares of Common Stock of the
Company (or such lesser number of shares as may be sold on behalf of the undersigned at the Closing) pursuant to the terms of the attached Warrant, or 

☐ elects to exercise its net issuance rights pursuant to Section 10.2 of the attached Warrant with respect to
             Shares of Common Stock. 
 2. Please deliver to the
custodian for the selling stockholders a stock certificate representing such              shares. 

3. The undersigned has instructed the custodian for the selling stockholders to deliver to the Company
$             or, if less, the net proceeds due the undersigned from the sale of shares in the aforesaid public offering. If such net proceeds are less than the purchase price for
such shares, the undersigned agrees to deliver the difference to the Company prior to the Closing. 
  

	
	
	                    
	(Signature)

  
  

            (Date)EX-4.6

 Exhibit 4.6 

MOHAWK GROUP HOLDINGS, INC. 

AMENDMENT NO. 1 TO REGISTRATION RIGHTS AGREEMENT 

This Amendment No. 1 to Registration Rights Agreement (this “Amendment”) is dated as of March 2, 2019 by and
among Mohawk Group Holdings, Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Investors attached hereto as EXHIBIT A (each, individually, an
“Investor” and, collectively, the “Investors”). 
 RECITALS 

WHEREAS, the Company, the Investors and certain other parties are parties to that certain Registration
Rights Agreement, dated as of April 6, 2018, pursuant to which the Company has an obligation, subject to certain conditions, to register with the Securities and Exchange Commission (the “SEC”) for resale certain
outstanding shares of Common Stock of the Company (the “Common Stock”) held by the Investors (the “Registration Rights Agreement”); 

WHEREAS, the Company has informed the Investors, on a confidential basis, that the Company intends to
file a registration statement on Form S-1 with the SEC with respect to a potential initial public offering of the Common Stock comprised solely of the sale of shares of Common Stock by (or on behalf of) the
Company (the “Potential IPO”); 
 WHEREAS, the Investors wish to facilitate the
Potential IPO; 
 WHEREAS, Section 11(k) of the Registration Rights Agreement provides, among
other things, that the provisions of the Registration Rights Agreement may be amended at any time and from time to time with and only with an agreement or consent in writing signed by the Company and the Majority Holders, and that, by the operation
of Section 11(k), the Majority Holders may have the right and power to diminish or eliminate all rights of the parties under the Registration Rights Agreement; 

WHEREAS, the Investors constitute the Majority Holders; 

WHEREAS, the Company and the Investors believe it appropriate to add all other stockholders of the
Company to this Agreement; and 
 WHEREAS, the Company and the Investors desire to amend the
Registration Rights Agreement as set forth herein. 
 NOW, THEREFORE, in consideration
of the foregoing premises and the mutual covenants and conditions set forth below, and in reliance on the recitals set forth above, and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties to this
Amendment hereby agree as follows: 
  

 ARTICLE 1 

AMENDMENT; WAIVER 
 1.1
Amendment and Restatement of Certain Definitions. The definitions of “Registration Filing Date”, “Registration Effectiveness Date”, “Holder”, and “Permitted Assignee” and Registrable Shares in
Section 1 of the Registration Rights Agreement are hereby amended and restated in their entirety as follows: 
 “Registration
Filing Date” means the earliest of: (i) in the event the Company withdraws from the Commission the Company’s registration statement on Form S-1 filed by the Company with the Commission for
the proposed initial public offering of the Common Stock (the “Withdrawal”), the date that is 30 days after the date of such Withdrawal; (ii) in the event the Company completes an initial public offering of the Common Stock
pursuant to a registration statement on Form S-1 declared effective by the Commission (the “IPO Closing”), the date that is 181 days after the date of the IPO Closing; and
(iii) December 31, 2019. 
 “Registration Effectiveness Date” means the earliest of: (i) in the event of a
Withdrawal, the date that is 90 days after the date of the filing of the Registration Statement with the Commission; (ii) in the event of an IPO Closing, the date that is 211 days after the date of the IPO Closing; and
(iii) January 31, 2020. 
 “Holder” means (i) each Purchaser, (ii) each Broker, (iii) each Pre-Merger Stockholder, (iv) each holder of the Merger Shares and (v) all other stockholders of the Company, in each case or any of such person’s respective successors and Permitted Assignees who
acquire rights in accordance with this Agreement with respect to any Registrable Shares directly or indirectly from a Purchaser or from any Permitted Assignee thereof. 

“Permitted Assignee” means (a) with respect to a partnership, its partners or former partners in accordance with their
partnership interests, (b) with respect to a corporation, its stockholders in accordance with their interest in the corporation, (c) with respect to a limited liability company, its members or former members in accordance with their
interest in the limited liability company, (d) with respect to an individual party, any Family Member or such party, (e) an entity or trust that is controlled by, controls, or is under common control with a transferor, (f) a party to
this Agreement, or (g) any underwriter or investment bank, as to the rights to enforce, at the Company’s expense (including reasonable attorneys’ fees and costs), or waive, in each case in whole or in part in their sole discretion,
obligations of Holders under Section 12 of this Agreement, as amended. 
 “Registrable Shares” means (a) the
Offering Shares, (b) the shares of Common Stock issuable upon exercise of the Placement Agent Warrants, (c) the Merger Shares, (d) the Pre-Merger Shares, and (e) the shares of Common Stock
owned by other Holders party hereto; but, in each case, excluding any otherwise Registrable Shares that (i) have been sold or otherwise transferred other than to a Permitted Assignee, or (ii) may be sold at the time under the Securities
Act without restriction, including manner of sale, current information requirements or volume limitations, either pursuant to Rule 144 of the Securities Act or otherwise, during any ninety (90) day period. 

  
 2 

 1.2 Waiver. The Investors, on behalf of all of the Holders, hereby waive any right to
assert or claim that the Company breached, violated or otherwise failed to comply with the Registration Rights Agreement by virtue of any action or inaction by the Company prior to the date hereof relating to: (a) any failure or purported
failure to file the Registration Statement with the Commission on or before the Registration Filing Date (as such term was defined prior to the date of this Amendment), or (b) the Registration Statement not being declared effective by the
Commission on or before the Registration Effectiveness Date (as such term was defined prior to the date of this Amendment). 
 1.3 Lock-Up Release. In the event of an IPO Closing, (a) Katalyst Securities LLC (“Katalyst”) agrees to release, and hereby releases, each holder of Common Stock (each, a
“Holder”) that is a party to a lock-up agreement or similar agreement entered into by and among the Company, Katalyst and such Holder on or before March 1, 2019 (each, a “Pre-Existing Lockup Agreement”) from such Holder’s obligations under such Pre-Existing Lockup Agreement beginning on the date that is 181 days after the date of
the IPO Closing, and (b) the Company agrees to release each Holder that is a party to a Pre-Existing Lockup Agreement from such Holder’s obligations under such
Pre-Existing Lockup Agreement beginning on the date that is 181 days after the date of the IPO Closing, or such longer period as is set forth on Schedule 1, Annex B. 

1.4 Amendment to Section 11(k). Section 11(k) of the Registration Rights Agreement is amended and restated in
its entirety as follows: “Except as otherwise provided herein, the provisions of this Agreement may be amended at any time and from time to time, and particular provisions of this Agreement may be waived, with and only with an agreement or
consent in writing signed by the Company and the Majority Holders; provided that this Agreement may not be amended and the observance of any term hereof may not be waived with respect to Holder: (i) if the amendment or waiver affects only
Holders of Registrable Shares of one category (a), (b), (c), (d), or (e) in the definition of Registrable Shares or changes the relative rights or preferences of such category and not another category or category without the written consent of
Holders of a majority of the Registrable Shares of any such category then outstanding; (ii) if the amendment or waiver affects the Holder of Registrable Shares of any such category differently than other Holders of Registrable Shares of such
category, without such Holder’s prior written consent; or (iii) if the amendment or waiver would have the effect of shortening the Lock-Up Periods in Schedule 1, Annex B. Subject to subsection
(iii) above, each Purchaser, Broker, Holder of Merger Shares and Holder of Pre-Merger Shares acknowledges that, by the operation of this Section, the Majority Holders, or the Holders of a majority of the
Registrable Shares of one of such categories, may have the right and power to diminish or eliminate all rights of the Purchaser, Broker, Holder of Merger Shares and Holder of Pre-Merger Shares or other shares
of Common Stock under this Agreement. Holders of equity securities of the Company may become parties to this Agreement by executing a counterpart of this Agreement without any amendment of this Agreement pursuant to this Section 11(k) or any
consent or approval of any other Holder, including any Purchaser or Broker.” 

  
 3 

 1.5 Amendment to Section 3(a). Section 3(a) of the
Registration Rights Agreement is amended to add the following phrase at the end of such sub-section, prior to the parenthetical: “fifth, from all other shares of Common Stock subject to this
Agreement, on a pro rata basis among the holders thereof”. 
 1.6 Lock-up Agreement. The
following shall be added as a new Section 12 of the Registration Rights Agreement: 
 “12.
Lock-up Agreement. 
 (a) Each Holder hereby agrees that, without the prior written consent of
the Company, such Holder will not, from the period from the date hereof until the applicable date that is set forth opposite such Holder’s name under the column “Lock-Up Expiration Date” (or any
shorter period or periods determined by the Company in its sole discretion) on Annex B hereto (each such period, a “Lock-Up Period”), (i) offer, pledge, sell, contract to sell, sell any
option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities
convertible into or exercisable or exchangeable for shares of capital stock of the Company, whether now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition
(collectively, the “Lock-Up Securities”); (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of Lock-Up Securities, whether any such transaction is to be settled by delivery of shares of Lock-Up Securities, in cash or otherwise; (iii) make any demand for or exercise
any right with respect to the registration of any Lock-Up Securities; or (iv) publicly disclose the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge
or other arrangement relating to any Lock-Up Securities. 
 (b) Notwithstanding the foregoing, and
subject to the conditions below, the restrictions contained in this Section 12 shall not apply to (i) transactions relating to Lock-Up Securities acquired in open market transactions after the date
of the final prospectus supplement related to the public offering of shares of Common Stock (the “Public Offering”) that is filed pursuant to Rule 424(b) of the Securities Act (the “Public Offering Date”); (ii)
transfers of Lock-Up Securities as a bona fide gift, by will or intestacy or to a Family Member of such Holder or trust for the direct or indirect benefit of such Holder or any Family Member of such Holder;
(iii) transfers of Lock-Up Securities to a charity or educational institution; (iv) if such Holder, directly or indirectly, controls or if the Holder is a corporation, partnership, limited liability
company or other business entity, any transfers of Lock-Up Securities to any shareholder, former shareholder, partner, former partner, member or former member of, or owner of similar equity interests in, such
Holder, as the case may be; (v) sales, forfeitures, withholdings or transfers pursuant to a net exercise of shares of Common Stock to cover the payment of the exercise prices or the payment or withholding of taxes associated with the exercise
or vesting of equity awards under any equity compensation plan of the Company; (vi) by operation of law (such as pursuant to a qualified domestic order or in connection with a divorce settlement); (vii) transfers to such Holder’s
affiliates (as defined in Rule 405 promulgated under the Securities Act) or to any investment fund or other entity controlled or managed by such Holder; and (viii) transfers of Lock-Up Securities to a
bona fide third party pursuant to a tender offer or any other 

  
 4 

 
transaction, including, without limitation, a merger, consolidation or other business combination, involving a change of control of the Company (including, without limitation, entering into any lock-up, voting or similar agreement pursuant to which such Holder agrees to transfer, sell, tender or otherwise dispose of Lock-Up Securities in connection with any such
transaction or vote any Lock-Up Securities in favor of any such transaction); provided that in the case of any transfer pursuant to the foregoing clauses (ii), (iii), (iv) or (vii), each transferee
shall sign and deliver to the Company a lock up agreement containing language substantially similar to the language of this Section 12; provided, further, that no filing under Section 16(a) of the Exchange Act shall be
required or shall be voluntarily made, except for a Form 5, or with respect to transfers pursuant to clause (v), (vi) or (viii), a filing on Form 4 or other public filing or announcement required to be filed or made if such filing or announcement
shall expressly state: in the case of clause (v), that the purpose of such sale, forfeiture, withholding or transfer pursuant to a net exercise of shares of Common Stock was to cover the payment of the exercise price or the payment of taxes; in the
case of clause (vi), that such transfer was pursuant to operation of law; and in case of clause (viii), that such transfer was made pursuant to a tender offer or such other applicable transaction; and provided further, that with respect to
transfers pursuant to clause (viii), all Lock-Up Securities subject to this Section 12 that are not so transferred, sold, tendered or otherwise disposed of remain subject to this Section 12, and it
shall be a condition of transfer, sale, tender or other disposition that if such tender offer or other transaction is not completed, any Lock-Up Securities subject to this Section 12 shall remain subject
to the restrictions herein. Such Holder also agrees and consents to the entry of stop transfer instructions with the Company’s transfer agent and registrar against the transfer of such Holder’s
Lock-Up Securities except in compliance with this Section 12. 
 (c) If the Holder is an officer
or director of the Company, the Company will announce any impending release or waiver of this Section 12 by press release through a major news service at least two business days before the effective date of the release or waiver. Any release or
waiver granted by the Company to any such officer or director shall only be effective two business days after the publication date of such press release. The provisions of this Section 12(c) will not apply if (i) the release or waiver is
effected solely to permit a transfer not for consideration, and (ii) the transferee has agreed in writing to be bound by the same terms described in this Section 12 to the extent and for the duration that such terms remain in effect at the
time of the transfer. 
 (d) Notwithstanding the foregoing, and subject to the conditions below, the restrictions contained in this
Section 12 shall also not apply to such Holder entering into a written trading plan established pursuant to Rule 10b5-1 under the Exchange Act during the applicable
Lock-Up Period, provided that (i) no direct or indirect offers, pledges, sales, contracts to sell, sales of any option or contract to purchase, purchases of any option or contract to sell, grants
of any option, right or warrant to purchase, loans or other transfers or disposals of any Lock-Up Securities may be effected pursuant to such plan during the Lock-Up
Period; and (ii) no filing under the Exchange Act, or other public filing, shall be required or voluntarily made, and no other public announcement shall be made, during the Lock-Up Period in connection
with entering into such plan, other than a filing on Form 5 made after the expiration of the Lock-Up Period. 

  
 5 

 (e) No provision in Section 12 shall be deemed to restrict or prohibit the exercise,
exchange, or conversion by such Holder of any securities exercisable or exchangeable for or convertible into Shares, as applicable; provided that such Holder does not transfer the Shares acquired on such exercise, exchange, or conversion
during the Lock-Up Period, unless otherwise permitted pursuant to the terms of this Section 12. 

(f) Such Holder further understands that the provisions of this Section 12 are irrevocable and shall be binding upon such Holder’s
heirs, legal representatives, successors and assigns. 
 (g) The Lock-Up Periods set forth in this
Section 12, including Annex B hereto, shall supersede any lock-up period set forth in a separate lock-up agreement or similar agreement entered into by and
among the Company, Katalyst Securities LLC and any holder of Lock-Up Securities on or before March 31, 2019.” 

1.7 Annex B. A new Annex B is hereby added to the Registration Agreement in the form of Schedule 1 attached hereto. 

ARTICLE 2 
 GENERAL
PROVISIONS 
 2.1 Capitalized Terms. All capitalized terms used in this Amendment, to the extent not otherwise defined herein, shall
have the meanings assigned to them in the Registration Rights Agreement. 
 2.2 Continuing Effectiveness. Except as modified by this
Amendment, the Registration Rights Agreement shall remain in full force and effect and no party by virtue of entering into this Amendment is waiving any rights it has under the Registration Rights Agreement, and once this Amendment is executed by
the parties hereto, all references in the Registration Rights Agreement to “the Agreement” or “this Agreement,” as applicable, shall refer to the Registration Rights Agreement as modified by this Amendment. 

2.3 Governing Law. This Amendment shall be governed by and construed in accordance with the laws of the United States of America and the
State of New York, both substantive and remedial, without regard to New York conflicts of law principles. Any judicial proceeding brought against either of the parties to this Amendment or any dispute arising out of this Amendment or any matter
related hereto shall be brought in the state or federal courts located in the County of New York in the State of New York and, by its execution and delivery of this Amendment, each party to this Amendment accepts the jurisdiction of such courts. The
foregoing consent to jurisdiction shall not be deemed to confer rights on any person other than the parties to this Amendment. 
 2.4
Counterparts. This Amendment may be executed in any number of counterparts, each of which shall be enforceable against the parties actually executing such counterparts, and all of which together shall constitute one instrument. In the event
that any signature is delivered by facsimile transmission or by an e-mail, which contains a portable document format (.pdf) file of an executed signature page, such signature shall create a valid and binding
obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or e-mail of a .pdf signature page were an original thereof. 

  
 6 

 2.5 Entire Agreement. This Amendment and the documents, instruments and other
agreements specifically referred to herein or delivered pursuant hereto constitute the full and entire understanding and agreement between the parties with regard to the subjects hereof. 

2.6 Permitted Assignees; Third Party Beneficiaries. The Company shall have the right to assign its rights to enforce and waive the
obligations set forth in Section 12 of the Registration Rights Agreement, as amended hereby, pursuant to an applicable underwriting agreement, to any underwriter, or investment bank engaged in an offering of securities of the Company, and in
such event each underwriter and bank shall be a Permitted Assignee of such rights. Each underwriter and bank shall be deemed an intended third party beneficiary of such rights, with the power to enforce or waive such obligations in whole or in part
in their sole discretion. 
 [Signature Page Follows] 

  
 7 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

			
	THE COMPANY:
	
	MOHAWK GROUP HOLDINGS, INC.,
	a Delaware corporation
		
	By:	 	 /s/ Yaniv Sarig

	Name:	 	Yaniv Sarig
	Title:	 	President and Chief Executive Officer

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

	
	INVESTOR:
	
	 Asher Delug

	Name
	
	 /s/ Asher Delug

	Signature

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

			
	INVESTOR:
	
	 Asher Maximus I, LLC

	Name of Entity
		
	By:	 	 /s/ Asher Delug

	Name: Asher Delug
	Title:

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

			
	INVESTOR:
	
	 MV II, LLC

	Name of Entity
		
	By:	 	 /s/ Lucile S. Yaney

	Name: Lucile S. Yaney
	Title:

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

	
	INVESTOR:
	
	 Yaniv Sarig

	Name
	
	 /s/ Yaniv Sarig

	Signature

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

							
	INVESTOR:	 		 	INVESTOR:
			
	 Eric Schwartz
	 		 	 1994, LLC

	Name	 		 	Name of Entity
				
	 /s/ Eric Schwartz
	 		 	By:	 	 /s/ Eric Schwartz

	Signature	 		 	 Name: Eric Schwartz

Title:

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

	
	INVESTOR:
	
	 Larisa Storozhenko

	Name
	
	 /s/ Larisa Storozhenko

	Signature

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

	
	INVESTOR:
	
	 Mihal Chaouat-Fix

	Name
	
	 /s/ Mihal Chaouat-Fix

	Signature

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

	
	INVESTOR:
	
	 Fabrice Hamaide

	Name
	
	 /s/ Fabrice Hamaide

	Signature

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

	
	INVESTOR:
	
	 Joseph A. Risico

	Name
	
	 /s/ Joseph A. Risico

	Signature

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

	
	INVESTOR:
	
	 Pete Datos

	Name
	
	 /s/ Pete Datos

	Signature

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

	
	INVESTOR:
	
	 Tomer Pascal

	Name
	
	 /s/ Tomer Pascal

	Signature

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 IN WITNESS WHEREOF, the
parties have executed this Amendment No. 1 to Registration Rights Agreement as of the date first above written. 
  

	
	INVESTOR:
	
	 Roi Zahut

	Name
	
	 /s/ Roi Zahut

	Signature

  
 [Signature Page to
Amendment No. 1 to Registration Rights Agreement] 

 Exhibit A 

Schedule of Investors 
  

					
	 Investor
	  	Registrable
Shares	 
	 Asher Delug
	  	 	9,231,463	 
	 Asher Maximus I, LLC
	  	 	1,699,731	 
	 MV II, LLC
	  	 	8,280,007	 
	 Yaniv Sarig
	  	 	1,679,360	 
	 Eric Schwartz
	  	 	290,822	 
	 1994, LLC
	  	 	1,647,995	 
	 Larisa Storozhenko
	  	 	5,366,147	 
	 Mihal Chaouat-Fix
	  	 	16,958	 
	 Fabrice Hamaide
	  	 	0	 
	 Joseph A. Risico
	  	 	0	 
	 Pete Datos
	  	 	0	 
	 Tomer Pascal
	  	 	0	 
	 Roi Zahut
	  	 	0	 
	 TOTAL
	  	 	28,212,483	 

  
 A-1 

 Schedule 1 

Annex B 
 Lock-up Periods 
  

			
	Holder Name	  	
Lock-Up Expiration Date (all references to numbers of

Registrable Shares shall be subject to adjustment for stock

splits, dividends or other distributions, recapitalizations or

similar events)

	Asher Delug	  	
•  With respect to 2,307,866 Registrable Shares: The date that is 12 months after the Public Offering
Date
  
 •  With respect to an
additional 2,307,866 Registrable Shares: The date that is 15 months after the Public Offering Date
  

•  With respect to an additional 2,307,866 Registrable Shares: The date that is 18 months after the
Public Offering Date
  
 •  With
respect to all other Lock-up Securities: The date that is 21 months after the Public Offering Date

	 	 
	Asher Maximus I, LLC	  	
•  With respect to 424,933 Registrable Shares: The date that is 12 months after the Public Offering
Date
  
 •  With respect to an
additional 424,933 Registrable Shares: The date that is 15 months after the Public Offering Date
  

•  With respect to an additional 424,933 Registrable Shares: The date that is 18 months after the
Public Offering Date
  
 •  With
respect to all other Lock-up Securities: The date that is 21 months after the Public Offering Date

	 	 
	MV II, LLC	  	
•  With respect to 2,070,002 Registrable Shares: The date that is 12 months after the Public Offering
Date
  
 •  With respect to an
additional 2,070,002 Registrable Shares: The date that is 15 months after the Public Offering Date
  

•  With respect to an additional 2,070,002 Registrable Shares: The date that is 18 months after the
Public Offering Date
  
 •  With
respect to all other Lock-up Securities: The date that is 21 months after the Public Offering Date    

  
 A-2 

			
	Holder Name	  	
Lock-Up Expiration Date (all references to numbers of

Registrable Shares shall be subject to adjustment for stock

splits, dividends or other distributions, recapitalizations or

similar events)

	Dr. Larisa Storozhenko	  	
•  With respect to 1,341,537 Registrable Shares: The date that is 9 months after the Public Offering
Date
  
 •  With respect to an
additional 1,341,537 Registrable Shares: The date that is 12 months after the Public Offering Date
  

•  With respect to an additional 1,341,537 Registrable Shares: The date that is 15 months after the
Public Offering Date
  
 •  With
respect to all other Lock-up Securities: The date that is 18 months after the Public Offering Date

	 	 
	 Yaniv Sarig

Mihal Chaouat-Fix
 Fabrice
Hamaide
 Joseph A. Risico
 Pete Datos

Tomer Pascal
 Roi Zahut
	  	With respect to the shares of Common Stock set forth on Exhibit A to the Amendment: the date that is 12 months after the Public Offering
Date
	 	 
	All Other Holders	  	With respect to all other shares of Common Stock: The date that is 180 days after the Public Offering Date

  
 A-3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00296-of-00352.parquet"}]]